1. Thrombin‐activatable fibrinolysis inhibitor influences disease severity in humans and mice with pneumococcal meningitis. (1st October 2015) Authors: Mook‐Kanamori, B. B.; Valls Serón, M.; Geldhoff, M.; Havik, S. R.; van der Ende, A.; Baas, F.; van der Poll, T.; Meijers, J. C. M.; P. Morgan, B.; Brouwer, M. C.; van de Beek, D. Journal: Journal of thrombosis and haemostasis Issue: Volume 13:Number 11(2015:Nov.) Page Start: 2076 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗